<?xml version="1.0" encoding="UTF-8"?>
<p>Patients with liver transplantation remain at increased risk for the development of active 
 <italic>Mycobacterium tuberculosis</italic> infection. Although it is optimal to treat latent TB prior to transplantation, it can be very difficult to do because of the significant hepatotoxicity of isoniazid. Treatment can sometimes be attempted after transplantation [
 <xref ref-type="bibr" rid="CR195">195</xref>].
</p>
